Skip to search formSkip to main contentSkip to account menu

copolymer I (synthetic peptide)

Known as: Cop 1, copolymer I, synthetic peptide copolymer I 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

(T,G)-A-Lsynthetic peptide
Multiple Sclerosisglatiramer acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Characterization of a Novel Non-Constitutive Photomorphogenic cop1 Allele1
A specific light program consisting of multiple treatments with alternating red and far-red light pulses was used to isolate… 
Highly Cited
1999
Highly Cited
1999
Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1.
The activity of copolymer 1 (Cop 1, Copaxone, glatiramer acetate) in suppressing experimental autoimmune encephalomyelitis (EAE… 
Review
1997
Review
1997
Cop 1 as a candidate drug for multiple sclerosis.
Copolymer 1 (Cop 1), a synthetic copolymer of amino acids, is very effective in suppression of experimental autoimmune… 
1996
1996
Combinations of drugs
  • L. Kappos
  • Multiple Sclerosis
  • 1996
  • Corpus ID: 9917094
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to… 
1990
1990
Cell-mediated immune response to copolymer I in multiple sclerosis measured by the macrophage procoagulant activity assay.
The macrophage/monocyte procoagulant activity (MPCA) assay, a sensitive and specific in vitro test for cell-mediated immunity… 
Highly Cited
1988
Highly Cited
1988
Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1.
Cop 1 is a synthetic basic random copolymer of L-alanine, L-glutamic acid, L-lysine, and L-tyrosine in a residue molar ratio of 6… 
Highly Cited
1987
Highly Cited
1987
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Cop 1 is a random polymer (molecular weight, 14,000 to 23,000) simulating myelin basic protein. It is synthesized by polymerizing… 
1986
1986
Human cellular immune response to copolymer I and myelin basic protein
Copolymer I (Cop I) is being tested as a treatment for MS because it protects animals against experimental allergic… 
1985
1985
Immunogenic potentials of copolymer I in normal human lymphocytes
Copolymer I (COP I), a nonencephalitogenic polypeptide analogous to myelin basic protein, is currently being tested for possible… 
Highly Cited
1982
Highly Cited
1982
Multiple sclerosis: Trial of a synthetic polypeptide
A synthetic polypeptide, copolymer I (COP I), composed of alanine, glutamic acid, lysine, and tyrosine, has been demonstrated to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)